These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31582737)

  • 1. Reduced mu opioid receptor availability in schizophrenia revealed with [
    Ashok AH; Myers J; Reis Marques T; Rabiner EA; Howes OD
    Nat Commun; 2019 Oct; 10(1):4493. PubMed ID: 31582737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [
    Shatalina E; Ashok AH; Wall MB; Nour MM; Myers J; Reis Marques T; Rabiner EA; Howes OD
    Neuroimage Clin; 2023; 39():103481. PubMed ID: 37517175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low μ-Opioid Receptor Status in Alcohol Dependence Identified by Combined Positron Emission Tomography and Post-Mortem Brain Analysis.
    Hermann D; Hirth N; Reimold M; Batra A; Smolka MN; Hoffmann S; Kiefer F; Noori HR; Sommer WH; Reischl G; la Fougère C; Mann K; Spanagel R; Hansson AC
    Neuropsychopharmacology; 2017 Feb; 42(3):606-614. PubMed ID: 27510425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability.
    Karjalainen T; Tuominen L; Manninen S; Kalliokoski KK; Nuutila P; Jääskeläinen IP; Hari R; Sams M; Nummenmaa L
    Soc Cogn Affect Neurosci; 2016 Aug; 11(8):1310-6. PubMed ID: 27053768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving.
    Gorelick DA; Kim YK; Bencherif B; Boyd SJ; Nelson R; Copersino M; Endres CJ; Dannals RF; Frost JJ
    Biol Psychiatry; 2005 Jun; 57(12):1573-82. PubMed ID: 15953495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms.
    Nuechterlein EB; Ni L; Domino EF; Zubieta JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous Opioid Mechanisms Are Implicated in Obesity and Weight Loss in Humans.
    Burghardt PR; Rothberg AE; Dykhuis KE; Burant CF; Zubieta JK
    J Clin Endocrinol Metab; 2015 Aug; 100(8):3193-201. PubMed ID: 26108093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interindividual variability and lateralization of μ-opioid receptors in the human brain.
    Kantonen T; Karjalainen T; Isojärvi J; Nuutila P; Tuisku J; Rinne J; Hietala J; Kaasinen V; Kalliokoski K; Scheinin H; Hirvonen J; Vehtari A; Nummenmaa L
    Neuroimage; 2020 Aug; 217():116922. PubMed ID: 32407992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.
    Johansson J; Hirvonen J; Lovró Z; Ekblad L; Kaasinen V; Rajasilta O; Helin S; Tuisku J; Sirén S; Pennanen M; Agrawal A; Crystal R; Vainio PJ; Alho H; Scheinin M
    Neuropsychopharmacology; 2019 Aug; 44(9):1667-1673. PubMed ID: 30867551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil.
    Heinz A; Reimold M; Wrase J; Hermann D; Croissant B; Mundle G; Dohmen BM; Braus DF; Schumann G; Machulla HJ; Bares R; Mann K
    Arch Gen Psychiatry; 2005 Jan; 62(1):57-64. PubMed ID: 15630073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. μ-opioid receptor system mediates reward processing in humans.
    Nummenmaa L; Saanijoki T; Tuominen L; Hirvonen J; Tuulari JJ; Nuutila P; Kalliokoski K
    Nat Commun; 2018 Apr; 9(1):1500. PubMed ID: 29662095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.
    Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME
    Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binge eating disorder and morbid obesity are associated with lowered mu-opioid receptor availability in the brain.
    Joutsa J; Karlsson HK; Majuri J; Nuutila P; Helin S; Kaasinen V; Nummenmaa L
    Psychiatry Res Neuroimaging; 2018 Jun; 276():41-45. PubMed ID: 29655552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An updated synthesis of [
    Blecha JE; Henderson BD; Hockley BG; VanBrocklin HF; Zubieta JK; DaSilva AF; Kilbourn MR; Koeppe RA; Scott PJH; Shao X
    J Labelled Comp Radiopharm; 2017 Jun; 60(8):375-380. PubMed ID: 28419528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant mesolimbic dopamine-opiate interaction in obesity.
    Tuominen L; Tuulari J; Karlsson H; Hirvonen J; Helin S; Salminen P; Parkkola R; Hietala J; Nuutila P; Nummenmaa L
    Neuroimage; 2015 Nov; 122():80-6. PubMed ID: 26260431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feeding Releases Endogenous Opioids in Humans.
    Tuulari JJ; Tuominen L; de Boer FE; Hirvonen J; Helin S; Nuutila P; Nummenmaa L
    J Neurosci; 2017 Aug; 37(34):8284-8291. PubMed ID: 28747384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of [
    Kelleher AC; Pearson TD; Ramsey J; Zhao W; O'Conor KA; Bakhoda A; Stodden T; Guo M; Eisenberg SM; Shah SV; Freaney ML; Kim W; Kang Y; Tomasi D; Johnson C; Fang CA; Volkow ND; Kim SW
    Sci Rep; 2024 Jul; 14(1):16250. PubMed ID: 39009645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional brain [(11)C]carfentanil binding following tobacco smoking.
    Domino EF; Hirasawa-Fujita M; Ni L; Guthrie SK; Zubieta JK
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jun; 59():100-104. PubMed ID: 25598501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperament trait Harm Avoidance associates with μ-opioid receptor availability in frontal cortex: a PET study using [(11)C]carfentanil.
    Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Raitakari O; Keltikangas-Järvinen L; Hietala J
    Neuroimage; 2012 Jul; 61(3):670-6. PubMed ID: 22484309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Building up analgesia in humans via the endogenous μ-opioid system by combining placebo and active tDCS: a preliminary report.
    DosSantos MF; Martikainen IK; Nascimento TD; Love TM; DeBoer MD; Schambra HM; Bikson M; Zubieta JK; DaSilva AF
    PLoS One; 2014; 9(7):e102350. PubMed ID: 25029273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.